Prof. Dr. ÖZDEN TACAL

Yayın Ağı

Makaleler 36

1. Thionine modulates tau phosphorylation in an Alzheimer's disease cell culture model

Onder S., BİBEROĞLU K., TACAL Ö.

TURKISH JOURNAL OF BIOLOGY , cilt.49, sa.4, ss.400-408, 2025 (SCI-Expanded, Scopus, TRDizin)

2. Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells

Onder S., BİBEROĞLU K., Yuksel M., TACAL Ö.

Chemico-Biological Interactions , cilt.366, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Chlorpyrifos oxon crosslinking of amyloid beta 42 peptides is a new route for generation of self-aggregating amyloidogenic oligomers that promote Alzheimer's disease

Onder S., BİBEROĞLU K., TACAL Ö., Schopfer L. M.

CHEMICO-BIOLOGICAL INTERACTIONS , cilt.363, 2022 (SCI-Expanded, Scopus)

4. Effects of toluidine blue O and methylene blue on growth and viability of pancreatic cancer cells

BİBEROĞLU K., YÜKSEL M., ÖNDER S., TACAL Ö.

DRUG DEVELOPMENT RESEARCH , cilt.83, sa.4, ss.900-909, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Butyrylcholinesterase in SH-SY5Y human neuroblastoma cells

Onder S., Schopfer L. M., Jiang W., TACAL Ö., Lockridge O.

NeuroToxicology , cilt.90, ss.1-9, 2022 (SCI-Expanded, Scopus)

6. Rabbit Antidiethoxyphosphotyrosine Antibody, Made by Single B Cell Cloning, Detects Chlorpyrifos Oxon-Modified Proteins in Cultured Cells and Immunopurifies Modified Peptides for Mass Spectrometry

ÖNDER S., van Grol M., Fidder A., Xiao G., Noort D., Yerramalla U., et al.

JOURNAL OF PROTEOME RESEARCH , cilt.20, sa.10, ss.4728-4745, 2021 (SCI-Expanded, Scopus)

7. Inhibition of cholinesterases by safranin O: Integration of inhibition kinetics with molecular docking simulations

ÖNDER S., SARI S., TACAL Ö.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.698, 2021 (SCI-Expanded, Scopus)

8. Characteristic fragment ions associated with dansyl cadaverine and biotin cadaverine adducts on glutamine

BİBEROĞLU K., Schopfer L. M., TACAL Ö., Lockridge O.

ANALYTICAL BIOCHEMISTRY , cilt.600, 2020 (SCI-Expanded, Scopus)

9. Chlorpyrifos Oxon-Induced Isopeptide Bond Formation in Human Butyrylcholinesterase

BİBEROĞLU K., TACAL Ö., Schopfer L. M., Lockridge O.

MOLECULES , cilt.25, sa.3, 2020 (SCI-Expanded, Scopus)

10. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by methylene violet 3RAX

Onder S., Biberoglu K., Tacal Ö.

CHEMICO-BIOLOGICAL INTERACTIONS , cilt.314, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review

YÜKSEL M., TACAL Ö.

EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.856, 2019 (SCI-Expanded, Scopus)

12. Azure B affects amyloid precursor protein metabolism in PS70 cells

BİBEROĞLU K., YÜKSEL M., TACAL Ö.

CHEMICO-BIOLOGICAL INTERACTIONS , cilt.299, ss.88-93, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Mass Spectral Detection of Diethoxyphospho-Tyrosine Adducts on Proteins from HEK293 Cells Using Monoclonal Antibody depY for Enrichment

Önder S., Schopfer L. M., Tacal Ö., Blake T. A., Johnson R. C., Lockridge O.

CHEMICAL RESEARCH IN TOXICOLOGY , cilt.31, ss.520-530, 2018 (SCI-Expanded, Scopus)

14. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease

YÜKSEL M., BİBEROĞLU K., ÖNDER S., Akbulut K. G., TACAL Ö.

BIOCHIMIE , cilt.146, ss.105-112, 2018 (SCI-Expanded, Scopus)

15. Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase

ÖNDER S., TACAL Ö., Lockridge O.

FRONTIERS IN PHARMACOLOGY , cilt.9, 2018 (SCI-Expanded, Scopus)

16. Use of Hupresin To Capture Red Blood Cell Acetylcholinesterase for Detection of Soman Exposure

ÖNDER S., SCHOPFER L. M., CASHMAN J. R., TACAL Ö., JOHNSON R. C., BLAKE T. K., et al.

ANALYTICAL CHEMISTRY , cilt.90, sa.1, ss.974-979, 2018 (SCI-Expanded, Scopus)

17. Monoclonal Antibody That Recognizes Diethoxyphosphotyrosine-Modified Proteins and Peptides Independent of Surrounding Amino Acids

ÖNDER S., Dafferner A. J., Schopfer L. M., Xiao G., Yerramalla U., TACAL Ö., et al.

CHEMICAL RESEARCH IN TOXICOLOGY , cilt.30, sa.12, ss.2218-2228, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Hupresin Retains Binding Capacity for Butyrylcholinesterase and Acetylcholinesterase after Sanitation with Sodium Hydroxide

ÖNDER S., DAVID E., TACAL Ö., SCHOPFER L. M., Lockridge O.

FRONTIERS IN PHARMACOLOGY , cilt.8, 2017 (SCI-Expanded, Scopus)

19. Effects of phenothiazine-structured compounds on APP processing in Alzheimer's disease cellular model

YÜKSEL M., BİBEROĞLU K., ÖNDER S., Akbulut K. G., TACAL Ö.

BIOCHIMIE , cilt.138, ss.82-89, 2017 (SCI-Expanded, Scopus)

20. Azure B reduces extracellular amyloid-beta levels in PS70 cells

BİBEROĞLU K., YÜKSEL TEK M., ÖNDER S., TACAL Ö.

FEBS JOURNAL , cilt.283, ss.266, 2016 (SCI-Expanded, Scopus)

21. Toluidine blue O is a potent inhibitor of human cholinesterases

BİBEROĞLU K., TEK M. Y., GHASEMI S., TACAL Ö.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.604, ss.57-62, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Healthy F-16 pilots show no evidence of exposure to tri-ortho-cresyl phosphate through the on-board oxygen generating system

Tacal O., Schopfer L. M.

CHEMICO-BIOLOGICAL INTERACTIONS , cilt.215, ss.69-74, 2014 (SCI-Expanded, Scopus)

23. Polyproline tetramer organizing peptides in fetal bovine serum acetylcholinesterase

BİBEROĞLU K., Schopfer L. M., Saxena A., TACAL Ö., Lockridge O.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS , cilt.1834, sa.4, ss.745-753, 2013 (SCI-Expanded, Scopus)

24. Determination of binding points of methylene blue and cationic phenoxazine dyes on human butyrylcholinesterase

Sezgin Z., BİBEROĞLU K., Chupakhin V., Makhaeva G. F., TACAL Ö.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.532, sa.1, ss.32-38, 2013 (SCI-Expanded, Scopus)

25. Resistance of Human Butyrylcholinesterase to Methylene Blue-Catalyzed Photoinactivation; Mass Spectrometry Analysis of Oxidation Products

TACAL Ö., Li B., Lockridge O., Schopfer L. M.

PHOTOCHEMISTRY AND PHOTOBIOLOGY , cilt.89, sa.2, ss.336-348, 2013 (SCI-Expanded, Scopus)

26. The proline-rich tetramerization peptides in equine serum butyrylcholinesterase

BİBEROĞLU K., Schopfer L. M., TACAL Ö., Lockridge O.

FEBS JOURNAL , cilt.279, sa.20, ss.3844-3858, 2012 (SCI-Expanded, Scopus)

27. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase

BİBEROĞLU K., TACAL Ö., Akbulut H.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.511, ss.64-68, 2011 (SCI-Expanded, Scopus)

28. Methamidophos, dichlorvos, O-methoate and diazinon pesticides used in Turkey make a covalent bond with butyrylcholinesterase detected by mass spectrometry

TACAL Ö., Lockridge O.

JOURNAL OF APPLIED TOXICOLOGY , cilt.30, sa.5, ss.469-475, 2010 (SCI-Expanded, Scopus)

29. Comparative Study of the Reduction of Phenoxazine and Phenothiazine Dyes by NADH in Aqueous Solution

Tacal O., Oezer I.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.34, sa.3, ss.128-133, 2009 (SCI-Expanded, Scopus, TRDizin)

30. Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase

Yucel Y. Y., TACAL Ö., Ozer I.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.478, sa.2, ss.201-205, 2008 (SCI-Expanded, Scopus)

31. An assessment of the role of intracellular reductive capacity in the biological clearance of triarylmethane dyes

Tacal O., Oezer I.

JOURNAL OF HAZARDOUS MATERIALS , cilt.149, sa.2, ss.518-522, 2007 (SCI-Expanded, Scopus)

32. Determination of alfa 1 proteinase inhibitor activity and phenotypes in patients with emphysema

TACAL Ö., Sümer N., ÇÖPLÜ L.

Turkish Journal Of Biochemistry-Turk Biyokimya Dergisi , cilt.31, ss.169-174, 2006 (TRDizin)

33. Inhibition of choline oxidase by quinoid dyes

Tacal O., Ozer I.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , cilt.21, sa.6, ss.783-787, 2006 (SCI-Expanded, Scopus)

34. Adduct-forming tendencies of cationic triarylmethane dyes with proteins: Metabolic and toxicological implications

Tacal O., Özer İ.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , cilt.18, sa.5, ss.253-256, 2004 (SCI-Expanded, Scopus)

35. A comparison between SDS-PAGE and size exclusion chromatography as analytical methods for determining product composition in protein conjugation reactions

Tacal O., Özer İ.

JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS , cilt.52, sa.3, ss.161-168, 2002 (SCI-Expanded, Scopus)

36. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: A comparison between equilibrium dialysis and fluorescence titration

Özer İ., Tacal O.

ANALYTICAL BIOCHEMISTRY , cilt.294, sa.1, ss.1-6, 2001 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 38

1. The effects of phenothiazine dyes on GAG-modified APLP2 and β-secretase 1 levels in Hs766t cells’’

BİBEROĞLU K., YÜKSEL M., ÖNDER S., TACAL Ö.

TBD Uluslararası Biyokimya Kongresi 2018 // 29. Ulusal Biyokimya Kongresi, 26 - 30 Ekim 2018, (Özet Bildiri)

2. Inhibition of human acetylcholinesterase and butyrylcholinesterase by methylene violet 3RAX

ÖNDER S., BİBEROĞLU K., TACAL Ö.

13th International Meeting on Cholinesterases, 9 - 14 Eylül 2018, (Özet Bildiri)

3. Detection of Diethoxyphospho-tyrosine Adducts on Proteins from HEK 293 Cells Using Monoclonal Antibody DepY for Enrichment

ÖNDER S., Schopfer L. M., TACAL Ö., Blake T. A., Johnson R. C., LOCKRIDGE O.

The 13th International Meeting on Cholinesterases and the 7th International Conference on Paraoxonases, 9 - 14 Eylül 2018, (Özet Bildiri)

4. Toluidine blue O reduces APLP2 and APLP2 CTF levels in Hs766T cells

BİBEROĞLU K., YÜKSEL M., ÖNDER S., TACAL Ö.

43rd FEBS Congress, 7 - 12 Temmuz 2018, (Özet Bildiri)

5. The Inhibitory effects of phenothiazine dyes on B-secretase

BİBEROĞLU K., YÜKSEL M., ÖNDER S., TACAL Ö.

12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Özet Bildiri)

6. Phenothiazine-structured compounds have different effects on secretases with therapeutic potential in Alzheimer’s disease

YÜKSEL M., TACAL Ö.

12th International Symposium on PharmaceuticalSciences, 26 - 29 Haziran 2018, (Özet Bildiri)

7. What Graduate Students Expect When They Enroll to Graduate Programs of Hacettepe University Institute of Health Sciences: Entrance Poll

KAYA K., PEHLİVANOĞLU B., TACAL Ö., ORHAN D.

International Meeting on Education Research in Health Sciences, 3 - 05 Kasım 2017, (Özet Bildiri)

8. Toluidine blue o but not thionine alters APP procesing in 3XTg-AD mice

YÜKSEL M., BİBEROĞLU K., ÖNDER S., AKBULUT K. G., TACAL Ö.

42nd Congress of the FEBS, 10 - 14 Eylül 2017, cilt.284, (Özet Bildiri)

9. Toluidine blue O, but not thionine, alters APP processing in 3xTg-AD mice

YÜKSEL M., BİBEROĞLU K., ÖNDER S., AKBULUT K. G., TACAL Ö.

42nd FEBS CONGRESS, 10 - 14 Eylül 2017, cilt.284, (Özet Bildiri)

10. Effect of toluidine blue O on tau pathology in an Alzheimer’xxs disease animal model.

YÜKSEL M., BİBEROĞLU K., ÖNDER S., AKBULUT K. G., TACAL Ö.

FEBS Advanced Lecture Course ALC17-012 Nuclear Receptors and Epigenomic Mechanisms in Human disease and Aging, 26 Ağustos - 01 Eylül 2017, (Özet Bildiri)

11. Effect of toluidine blue O on tau pathology in an Alzheimer’s disease animal model

YÜKSEL M., BİBEROĞLU K., ÖNDER S., AKBULUT K. G., TACAL Ö.

FEBS Advanced Lecture Course ALC17-012 Nuclear Receptors and Epigenomic Mechanisms in Human Disease and Aging, Spetses, Yunanistan, 26 Ağustos - 01 Eylül 2017, (Özet Bildiri)

12. The General Information About the Active Supervisiors of Hacettepe University Institute of Health Sciences

ÖZTÜRK ÇOPUR E., PEHLİVANOĞLU B., TACAL Ö., ORHAN D.

12th ORPHEUS Conference “PhD Training in Health Sciences and Biomedicine from the Interdiciplinary Perspective, Klaipeda, Litvanya, 4 - 06 Mayıs 2017, (Özet Bildiri)

13. EVALUATION OF CURRENT STATUS AND SCIENTIFIC ACTIVITIES OF THE GRADUATE STUDENTS OF HACETTEPE UNIVERSITY INSTITUTE OF HEALTH SCIENCES IN 2016.

ÖZTÜRK ÇOPUR E., PEHLİVANOĞLU B., TACAL Ö., ORHAN D.

12th ORPHEUS Conference, Klaipeda, Litvanya, 4 - 06 Mayıs 2017, (Özet Bildiri)

14. Evaluation of Current Status and Scientific Activities of the Graduate Students in Hacettepe University Institute of Health Sciences in 2016

ÖZTÜRK ÇOPUR E., PEHLİVANOĞLU B., TACAL Ö., ORHAN D.

ORPHEUS Conference “PhD Training in Health Sciences and Biomedicine from the Interdiciplinary Perspective”, Klaipeda, Litvanya, 4 - 06 Mayıs 2017, (Özet Bildiri)

15. THE GENERAL INFORMATON ABOUT THE ACTIVE SUPERVISORS OF HACETTEPE UNIVERSITY INSTITUTE OF HEALTH SCIENCES IN 2016.

PEHLİVANOĞLU B., ÖZTÜRK ÇOPUR E., TACAL Ö., ORHAN D.

12th ORPHEUS Conference, Klaipeda, Litvanya, 4 - 06 Mayıs 2017, (Özet Bildiri)

16. The Graduate’s Perspective for the Education in Hacettepe University Institute of Health Sciences

ÖZTÜRK ÇOPUR E., PEHLİVANOĞLU B., TACAL Ö., ORHAN D.

12th ORPHEUS Conference “PhD Training in Health Sciences and Biomedicine from the Interdiciplinary Perspective, Klaipeda, Litvanya, 4 - 06 Mayıs 2017, (Özet Bildiri)

17. Monoclonal antibodies that recognize diethoxyphosphate-tyrosine modified proteins

ÖNDER S., Dafferner A., Schopfer L. M., Blake T. A., Rudolph C J., TACAL Ö., et al.

2017 Society for Developmental Biology West Coast Regional Meeting, Yosemite, Amerika Birleşik Devletleri, 28 - 31 Mart 2017, (Özet Bildiri)

18. New Standard Flow UPLC Method for Identification of CaCo2 Cell Line Proteome

KOÇAK E., ÇELEBİER M., BİBEROĞLU K., TACAL Ö., ALTINÖZ S.

10 Aegean Analytical Chemistry Days, 26 Eylül - 02 Ekim 2016, (Özet Bildiri)

19. The extracellular A beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer's disease-like cellular model

Tek M. Y., BİBEROĞLU K., ÖNDER S. Ç., Akbulut K. G., TACAL Ö.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.321, (Özet Bildiri)

20. Azure B reduces extracellular amyloid-beta levels in PS70 cells

BİBEROĞLU K., Tek M. Y., ÖNDER S. Ç., TACAL Ö.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.266, (Özet Bildiri)

21. The effect of thionine on amyloid beta peptide levels in PS70 cells

YÜKSEL TEK M., BİBEROĞLU K., Önder S., AKBULUT K. G., TACAL Ö.

12th International Meeting on Cholinesterases-Sixth International Conference on Paraoxonases, 27 Eylül - 02 Ekim 2015, (Özet Bildiri)

22. The effect of thionine on amyloid b peptide levels in PS70 cells

YÜKSEL TEK M., BİBEROĞLU K., SEDA O., AKBULUT K. G., Tacal Ö.

12th International Meeting on Cholinesterases-Sixth Internatonal Conference on Paraoxonases, Elche, İspanya, 27 Eylül - 02 Ekim 2015, (Özet Bildiri)

23. THE EFFECT OF TOLUIDINE BLUE O ON AMYLOID b PEPTIDE LEVELS IN HUMAN NEUROBLASTOMA CELLS

YÜKSEL TEK M., BİBEROĞLU K., ÖNDER S., AKBULUT K. G., TACAL Ö.

40th Congress of The Federation of European Biochemical Societies (FEBS), 4 - 09 Temmuz 2015, cilt.282, ss.177

24. The effect of toluidine blue O on amyloid-beta peptide levels in human neuroblastoma cells

Tek M. Y., BİBEROĞLU K., ÖNDER S. Ç., Akbulut K. G., TACAL Ö.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Almanya, 4 - 09 Temmuz 2015, cilt.282, ss.177, (Özet Bildiri)